Prognosis, Cost, and Occurrence of Colorectal, Lung, Breast, and Prostate Cancer in Hungary
- 1 September 2015
- journal article
- Published by Elsevier in Value in Health Regional Issues
- Vol. 7, 1-8
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Comorbidity and survival of Danish lung cancer patients from 2000–2011: a population-based cohort studyClinical Epidemiology, 2013
- Comorbidity and survival of Danish prostate cancer patients from 2000–2011: a population-based cohort studyClinical Epidemiology, 2013
- Physical, Psychosocial, Relationship, and Economic Burden of Caring for People With Cancer: A ReviewJournal of Oncology Practice, 2013
- Factors related with symptom duration until diagnosis and treatment of symptomatic colorectal cancerBMC Cancer, 2013
- Time intervals from first symptom to treatment of cancer: a cohort study of 2,212 newly diagnosed cancer patientsBMC Health Services Research, 2011
- Treatment Delays in Non-small Cell Lung Cancer and Their Prognostic ImplicationsJournal of Thoracic Oncology, 2011
- Az onkológiai gyógyszerekre fordított éves egészségbiztosítási kiadások meghatározása MagyarországonMagyar Onkologia, 2010
- How Much Is Life Worth: Cetuximab, Non-Small Cell Lung Cancer, and the $440 Billion QuestionJNCI: Journal of the National Cancer Institute, 2009
- Time spans from first symptom to treatment in patients with lung cancer – The influence of symptoms and demographic characteristicsActa Oncologica, 2008
- Cost of Cancer Care: Issues and ImplicationsJournal of Clinical Oncology, 2007